Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Petersen

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Psychiatry Research|May 22, 2003
Somatic symptoms in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, John Denninger, et al.
The Journal of Nervous and Mental Disease|August 2, 2003
Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcomeGeorge I Papakostas, Timothy Petersen, Joel Pava, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 21, 2002
A survey of prescribing practices in the treatment of depressionTimothy Petersen, Christina Dording, Nicole B Neault, et al.
Neuropsychobiology|May 22, 2003
Serum cholesterol in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, Shamsah B Sonawalla, et al.
Psychosomatic Medicine|October 6, 2005
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorderDan V Iosifescu, Nicoletta Clementi-Craven, Renerio Fraguas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 16, 2004
Psychosocial functioning in patients with treatment resistant depressionTimothy Petersen, George I Papakostas, Yasmin Mahal, et al.
Journal of Clinical Psychopharmacology|January 25, 2003
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressantsAndrew A Nierenberg, George I Papakostas, Timothy Petersen, et al.
Psychiatry Research|June 12, 2003
Serum cholesterol and serotonergic function in major depressive disorderGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
Journal of Clinical Psychopharmacology|September 7, 2004
Psychosocial functioning during the treatment of major depressive disorder with fluoxetineGeorge I Papakostas, Timothy Petersen, John W Denninger, et al.
Comprehensive Psychiatry|January 14, 2003
Functioning and interpersonal relationships as predictors of response in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Psychiatry Research|May 22, 2003
Somatic symptoms in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, John Denninger, et al.
The Journal of Nervous and Mental Disease|August 2, 2003
Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcomeGeorge I Papakostas, Timothy Petersen, Joel Pava, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 21, 2002
A survey of prescribing practices in the treatment of depressionTimothy Petersen, Christina Dording, Nicole B Neault, et al.
Neuropsychobiology|May 22, 2003
Serum cholesterol in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, Shamsah B Sonawalla, et al.
Psychosomatic Medicine|October 6, 2005
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorderDan V Iosifescu, Nicoletta Clementi-Craven, Renerio Fraguas, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 16, 2004
Psychosocial functioning in patients with treatment resistant depressionTimothy Petersen, George I Papakostas, Yasmin Mahal, et al.
Journal of Clinical Psychopharmacology|January 25, 2003
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressantsAndrew A Nierenberg, George I Papakostas, Timothy Petersen, et al.
Psychiatry Research|June 12, 2003
Serum cholesterol and serotonergic function in major depressive disorderGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
Journal of Clinical Psychopharmacology|September 7, 2004
Psychosocial functioning during the treatment of major depressive disorder with fluoxetineGeorge I Papakostas, Timothy Petersen, John W Denninger, et al.
Comprehensive Psychiatry|January 14, 2003
Functioning and interpersonal relationships as predictors of response in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
Pageof 6